Systematic review of 24 studies (21 meta-analysed) in hidradenitis suppurativa: across 10 RCTs, new-onset IBD occurred in 6 of 2572 patients on IL-17 inhibitors vs 0 of 1066 on placebo to week 16, not a significant difference. IBD events were rare.
Meta-analysisn = 24 studies
Cutrona et al. Inflammatory Bowel Disease and Interleukin-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis